Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer
Figure 3
Kaplan Meyer survival curve (KMSC). (a) The KMSC showing significantly higher one-year mortality rate in male than in female in the same setting of end-stage of non-small cell lung cancer (ES-NSCLC). (b) The KMSC showing significantly higher one-year mortality rate in disease control than in disease progression. (c) The KMSC showing significantly higher one-year mortality rate in circulating level of (EDAc-) MPs ≥ 1100.5 counts/mL than that of this biomarker <1100.5 counts/mL. However, the statistical significance only occurred at late stage of the first year. (d) The KMSC showing significantly higher one-year mortality rate in presence than in absence of brain metastasis.
